ResearcherUniversity Hospital MagdeburgActive in the last 2 years
Wenjie Shi
Matched on ORCID iD 0009-0003-4186-9191; OpenAlex author ID A5037891463. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2022: 1 paper · 2023: none · 2024: 1 paper
Papers 2
- Nanoformulation of dasatinib cannot overcome therapy resistance of pancreatic cancer cells with low LYN kinase expression. Co-author DOI 10.1007/s43440-024-00600-w↗
- Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents. Co-author DOI 10.3390/jpm12030478↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ulf D. Kahlert · 2 shared papers, 2022–2024 · strength 0.44
- Paper Nanoformulation of dasatinib cannot overcome therapy resistance of pancreatic cancer cells with low LYN kinase expressi… DOI 10.1007/s43440-024-00600-w↗
- Paper Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Rep… DOI 10.3390/jpm12030478↗
- Marilyn Kaul · 1 shared paper, 2024 · strength 0.28
- Thomas Baptist Brunner · 1 shared paper, 2022 · strength 0.16
- Christoph Kahlert · 1 shared paper, 2022 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.